Welcome and introduction (ID 6234)
How Would You Assess Risk of Recurrence in This Patient With HR+/HER2- EBC? Patient video will be included (ID 6235)
Treatment Considerations for Patients With High-Risk HR+/HER2- EBC: What do the Latest Data Show? (ID 6236)
Keeping the Patient Central: Discussing Adherence and Persistence and the Role of the MDT Patient (ID 6237)
Concluding Remarks (ID 6238)
